Everolimus after failure of one prior VEGF ‐targeted therapy in metastatic renal cell carcinoma: Final results of the MARC ‐2 trial-Reference-Cited by-同舟云学术

Everolimus after failure of one prior VEGF ‐targeted therapy in metastatic renal cell carcinoma: Final results of the MARC ‐2 trial

Published:2020-10-26 Issue:7 Volume:148 Page:1685-1694
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Staehler Michael¹^ORCID,Stöckle Michael²,Christoph Daniel C.³⁴,Stenzl Arnulf⁵,Potthoff Karin⁶,Grimm Marc‐Oliver⁷,Klein Dunja⁶,Harde Johanna⁸,Brüning Fabian⁹,Goebell Peter J.¹⁰,Augustin Marinela¹¹,Roos Frederik¹²,Benz‐Rüd Iris⁶,Marschner Norbert¹³^ORCID,Grünwald Viktor¹⁴¹⁵

Affiliation:

1. Department of Urology, Interdisciplinary Center of Renal Tumors Ludwig‐Maximilians‐University of Munich Munich Germany

2. Department of Urology and Paediatric Urology Saarland University Medical Center Homburg (Saar) Germany

3. Department of Medical Oncology University Hospital Essen Essen Germany

4. Department of Medical Oncology & Hematology Evang. Kliniken Essen‐Mitte, Evang. Huyssens‐Stiftung Essen‐Huttrop Essen Germany

5. Department of Urology University Hospital Tuebingen Tübingen Germany

6. Medical Department iOMEDICO Freiburg im Breisgau Germany

7. Department of Urology University Hospital Jena Jena Germany

8. Biostatistics, iOMEDICO Freiburg im Breisgau Germany

9. Department of Urology and Pediatric Urology Philipps‐University Marburg, University Hospital Giessen and Marburg GmbH Marburg Germany

10. Department of Urology and Clinic for Haematology and Internistic Oncology University Hospital Erlangen, Ambulatory Uro‐Oncological Therapy Unit Erlangen (AURONTE) Erlangen Germany

11. Department of Hematology and Oncology Klinikum Nuremberg, Paracelsus Medical University Nürnberg Germany

12. Department of Urology University Hospital Frankfurt Frankfurt Germany

13. Outpatient‐Centre for Interdisciplinary Oncology and Haematology Freiburg Germany

14. Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation University Hospital Hannover Medical School Hannover Germany

15. Clinic for Internal Medicine (Tumour Research) and Clinic for Urology, West German Cancer Center University Hospital Essen Essen Germany

Funder

Novartis Pharma

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33349

Reference27 articles.

1. Sunitinib Efficacy Against Advanced Renal Cell Carcinoma

2. Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

3. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

5. Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of multiple risk factors for colorectal cancer relapse after laparoscopic radical resection;World Journal of Gastrointestinal Surgery;2023-10-27

2. Metamorphic Effect of Angiogenic Switch in Tumor Development: Conundrum of Tumor Angiogenesis Toward Progression and Metastatic Potential;Biomedicines;2023-07-29

3. Impact of BMI on the Survival of Renal Cell Carcinoma Patients Treated with Targeted Therapy: A Systematic Review and Meta-Analysis;Nutrition and Cancer;2023-07-18

4. Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs;Diagnostics;2023-01-05

5. Jagged-1 is induced by mTOR inhibitors in renal cancer cells through an Akt/ALK5/Smad4-dependent mechanism;Current Research in Pharmacology and Drug Discovery;2022